Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial

BACKGROUND: Higher serum phosphate and fibroblast growth factor-23 (FGF23) levels may be modifiable to prevent cardiovascular disease in CKD. Short-term studies have reported modest efficacy in phosphate and FGF23 reduction with intestinal phosphate binders in CKD. METHODS: To investigate effects of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Ix, Joachim H., Isakova, Tamara, Larive, Brett, Raphael, Kalani L., Raj, Dominic S., Cheung, Alfred K., Sprague, Stuart M., Fried, Linda F., Gassman, Jennifer J., Middleton, John P., Flessner, Michael F., Block, Geoffrey A., Wolf, Myles
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2019
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6551774/
https://ncbi.nlm.nih.gov/pubmed/31085679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2018101058
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados